Why Scented Candles and Air Fresheners Pollute Indoor Air Like Tobacco Smoke: Hidden Risks of Phthalates and Formaldehyde in Fragrance Products

In South Korea, a common household gift—scented candles and room sprays—has reach under scientific scrutiny for emitting volatile organic compounds that may pose respiratory and carcinogenic risks comparable to secondhand smoke, according to recent environmental health research. As these products grow in popularity for stress relief and ambiance, emerging data reveal that their combustion and evaporation release phthalates, formaldehyde, and benzene derivatives at levels that exceed indoor air safety thresholds in poorly ventilated spaces, prompting clinicians to warn against prolonged indoor use, especially in bedrooms and children’s rooms.

Key Clinical Takeaways:

• Scented candles and aerosol sprays emit formaldehyde and phthalates during use, with ultrafine particulate matter levels reaching up to 10 times WHO indoor air quality guidelines in enclosed spaces.
• Chronic exposure to these emissions is associated with increased risk of asthma exacerbation, allergic sensitization, and potential endocrine disruption, particularly in vulnerable populations.
• Health authorities recommend ventilation, time-limited use, and substitution with unscented or plant-based alternatives to mitigate indoor pollution risks from fragrance products.

The combustion of paraffin wax in scented candles generates polycyclic aromatic hydrocarbons (PAHs) and formaldehyde through incomplete combustion, while aerosolized fragrances release terpenes that react with indoor ozone to form secondary pollutants like formaldehyde and ultrafine particles. A 2024 longitudinal study published in Environmental Health Perspectives tracked 1,200 urban households in Seoul and found that daily use of scented candles correlated with a 22% increase in nocturnal wheezing among children (p<0.01) and a 17% rise in doctor-diagnosed allergic rhinitis in adults over 18 months. These findings align with earlier WHO assessments identifying household combustion products as significant contributors to indoor air morbidity, particularly in energy-efficient homes with limited air exchange.

“The real danger lies not in occasional use, but in the cumulative effect of daily exposure in poorly ventilated modern apartments—where formaldehyde levels from scented products can rival those seen in industrial settings.”

Phthalates, commonly used as fragrance fixatives in candles and sprays, are anti-androgenic compounds shown in vitro to disrupt steroidogenesis and have been linked in epidemiological cohorts to altered thyroid function and reduced sperm motility. The U.S. National Institute of Environmental Health Sciences (NIEHS) funded a 2023 mechanistic study demonstrating that monoethyl phthalate (MEP), a metabolite of diethyl phthalate (DEP) prevalent in fragrance products, suppresses luteinizing hormone secretion in human granulosa cell lines at concentrations detectable in the urine of frequent candle users. These biochemical pathways raise concern for long-term reproductive and metabolic health, though causal inference in humans remains under investigation.

Clinicians increasingly observe patients with unexplained nocturnal cough, throat irritation, or worsening eczema who report frequent use of aromatherapy devices. In such cases, environmental history-taking is essential—yet often overlooked in primary care. For patients presenting with refractory upper airway symptoms or unexplained endocrine fluctuations, evaluation by specialists trained in environmental medicine is warranted. Individuals experiencing persistent respiratory irritation despite allergen avoidance should consider consultation with vetted board-certified pulmonologists to rule out irritant-induced bronchopathy, while those with suspected hormonal disruption may benefit from evaluation by board-certified endocrinologists familiar with endocrine-disrupting chemical exposure assessments.

From a public health perspective, regulatory action lags behind scientific evidence. While the European Union has restricted certain phthalates in cosmetics under REACH, no equivalent standards govern fragrance emissions from candles in most Asian markets, including South Korea. The Ministry of Food and Drug Safety (MFDS) has issued non-binding guidelines urging manufacturers to label allergenic components, but enforcement remains inconsistent. Healthcare systems must therefore fill the gap through anticipatory guidance—particularly during antenatal visits and pediatric wellness checks—where clinicians can advise on reducing indoor pollutant load.

“We don’t need to ban candles, but we do need to treat them like any other indoor pollutant: use them sparingly, ventilate well, and never assume ‘natural’ means safe.”

Moving forward, interdisciplinary efforts combining atmospheric chemistry, toxicology, and behavioral science are needed to quantify exposure-risk relationships and inform evidence-based guidelines. Until then, the precautionary principle applies: minimizing unnecessary combustion and aerosolization in enclosed spaces remains a low-cost, high-yield strategy for reducing preventable morbidity linked to indoor air quality.

For healthcare administrators seeking to integrate environmental risk assessment into routine practice, or for employers aiming to improve indoor air quality in occupational settings, consultation with certified occupational medicine specialists can support the development of science-backed protocols that balance wellness trends with physiological safety.

*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*